How to Monitor Borderline Symptoms With the Brazilian BSL-23
How can clinicians use the Brazilian Portuguese BSL-23 to follow borderline symptom change over time?
Patients with borderline personality disorder often require repeated assessment of symptom burden during treatment and follow-up. This guide applies when clinicians in Brazil want a brief tool for routine outcome monitoring, treatment-response tracking, and longitudinal appraisal of symptom trajectories.
-
Use the BSL-23 for repeated weekly symptom appraisal
Administer the Brazilian Portuguese BSL-23 at repeated time points when you need to track change, because each item refers to the previous week. Its 23-item format reduces respondent burden and supports practical serial use in treatment and follow-up settings.
-
Track the total score across visits
Compare the patient's total score over successive administrations to trace symptom trajectories over time. The article identifies longitudinal appraisal of symptom change as a particularly well-substantiated clinical application of the BSL-23 and notes that its short form was derived partly from items with pronounced sensitivity to change.
-
Use changes to inform treatment response discussions
Use rising or falling total scores as one component of treatment-response appraisal and routine outcome monitoring. The discussion notes that prior work demonstrated detectable pre-post change over 3 months of dialectical behavior therapy and that later psychotherapy studies have continued to use the BSL-23 as an outcome measure.
-
Pay added attention to self-directed negativity in highly symptomatic patients
When scores are high, review whether self-punitive and self-harm-related experiences are becoming more prominent. In the high-symptom network, item 12, "I wanted to punish myself," was the most central node, and high-severity participants also showed elevated activation for items 12, 09, 13, 05, and 14.
-
Avoid overinterpreting symptom-network findings
Use network findings only as contextual information when reflecting on symptom patterns over time. The authors caution that network centrality does not imply symptom frequency or causal primacy, so these findings should not be treated as a treatment hierarchy or causal map.
Clinical Considerations
- The study did not examine test-retest reliability, which is directly relevant to instruments used for monitoring change over time.
- The paper supports symptom tracking and treatment-response appraisal, but it does not provide a specific retesting interval beyond the scale's previous-week time frame.
- Network findings about central symptoms should be interpreted cautiously because centrality does not establish causality or symptom priority.
- Because the validation sample was nonclinical, the study does not define clinically meaningful change thresholds for practice use.
Bottom Line
The strongest clinical use of the Brazilian Portuguese BSL-23 is repeated measurement of total borderline symptom burden over time to support routine outcome monitoring and treatment-response tracking.
